Iran to produce US-, Europe-licensed drugs
Iran's pharmaceutical industry is relatively advanced./ Iran will open a production line for branded generic drugs licensed by European and American companies on Thursday, a local formulator says. The plant in Saveh, about 100 km southwest of Tehran, has been built with $8 million of investment, CEO of Behestan Pharmaceutical Co. Mehdi Balochestani said. It will initially produce 12 brands of drugs for treatment of diabetes, neurological diseases, inflammations and prostates, which will be on pharmacy shelves in the next two months. Five ...
Click
To Read Full Article